QUANTITATION OF DIALYSIS - THE IMPORTANCE OF MEMBRANE AND MIDDLE MOLECULES

被引：20
作者：
CHEUNG, AK
机构：
[1] Division of Nephrology and Hypertension, University of Utah, School of Medicine, Veterans Affairs Medical Center, Salt Lake City, UT
来源：
BLOOD PURIFICATION | 1994年 / 12卷 / 01期
关键词：
HEMODIALYSIS; PERITONEAL DIALYSIS; MIDDLE MOLECULES; UREMIC TOXINS; UREA KINETICS; MEMBRANES; BETA-2-MICROGLOBULIN; CLEARANCE; BIOCOMPATIBILITY;
D O I：
10.1159/000170144
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Despite the availability of calcitriol and recombinant erythropoietin to replace two major endocrine functions of the kidneys, mortality in chronic hemodialysis patients remains substantially higher than that in the general population. This suggests that most, if not all, patients are underdialyzed. While increasing small solute clearance by dialysis using urea kinetics as a guide improves clinical outcome,'adequate' treatment using current techniques is only an arbitrary definition, since solute removal by dialysis remains far inferior to that of the normal native kidneys. In recent years, significant advances have been made in the structural and functional characterization of toxic uremic solutes that are in the higher molecular size range ('middle molecules'). Several lines of evidence suggest that, in addition to small solutes, removal of middle molecules is also advantageous. The potential beneficial effects of synthetic high flux hemodialysis membranes are probably attributed to both their solute clearance profiles as well as their biocompatibility characteristics.
引用
收藏
页码：42 / 53
页数：12
相关论文
共 40 条
  • [1] May R.C., Kelly R.A., Milch W.E., Pathophysiology of uremia, The Kidney, 2, pp. 1997-2018, (1991)
  • [2] Tsukamoto Y., Saka S., Kurnano K., Iwanami S., Ishida O., Marumo F., Abnormal accumulation of vanadium in patientson chronic hemodialysis therapy, Nephron, 56, pp. 368-373, (1990)
  • [3] Grollman E.F., Grollman A., Toxicity of urea and its role in the pathogenesis of uremia, J Clin Invest, 38, pp. 749-754, (1959)
  • [4] Johnson W.J., Hagge W.W., Wagoner R.D., Dinapoli R.P., Rosevear J.W., Effects of urea loading in patients with far-advanced renal failure, Mayo Clin Proc, 47, pp. 21-29, (1972)
  • [5] Lowrie E.G., Laird N.M., Parker T.F., Sargent J.A., Effect of hemodialysis prescription on patient morbidity: Report from the National Cooperative Dialysis Study, N Engl J Med, 305, pp. 1176-1181, (1981)
  • [6] Tenckhoff H., Curtis F.K., Experience with maintenance peritoneal dialysis in the home, Trans Am Soc Artif Intern Organs, 16, pp. 90-95, (1970)
  • [7] Jebsen R.H., Tcnckhoff H., Hoult J.C., Natural history of uremic polyneuropathy and the effects of dialysis, N Engl J Med, 277, pp. 327-333, (1967)
  • [8] Held P.J., Levin N.W., Randall R., Bovbjerg J.D., Pauly M.V., Diamond L.H., Mortality and duration of hemodialysis treatment, JAMA, 265, pp. 871-875, (1991)
  • [9] Keshaviah P., Collins A., Rapid high- efficiency bicarbonate hemodialysis, Trans Am Soc Artif Intern Organs, 32, pp. 17-23, (1986)
  • [10] Chanard J., Lavaud S., Toupance O., Roujouleh H., Melin J.-P., Carpal tunnel syndrome and type of dialysis membrane used in patients undergoing long-term hemodialysis, Arthritis Rheum, 29, pp. 1170-1171, (1986)
1234